Lead Compound Refinement

Lead Compound Refinement is a methodological process within ligand efficiency optimization that systematically modifies the structural and physicochemical properties of a lead compound to enhance its binding affinity, selectivity, and drug-like characteristics while maintaining optimal ligand efficiency.

15

Publications

664

Citations

79

Authors

14

Institutions

Publications per year

2017–2026

3

Authors

79

  1. AT
    Attilla Ting

    AstraZeneca (United Kingdom), United Kingdom

    1 publications · 15 citations

    1

    h-index

  2. RP
    Raimon Puig de la Bellacasa

    Universitat Ramon Llull, Spain

    1 publications · 14 citations

    1

    h-index

  3. BC
    Beining Chen

    University of Sheffield, United Kingdom

    1 publications · 76 citations

    1

    h-index

  4. SG
    S. Gerhardt

    University of Freiburg, Germany

    1 publications · 15 citations

    1

    h-index

  5. JP
    Jason Pickens

    Takeda (United States), United States

    1 publications · 43 citations

    1

    h-index

1–5 of 79

Venues

  1. Bioorganic & Medicinal Chemistry

    2 publications · 68 citations

    2

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    1 publications · 15 citations

    1

    h-index

  3. Main Group Metal Chemistry

    1 publications · 25 citations

    1

    h-index

  4. Acta Crystallographica

    1 publications · 30 citations

    1

    h-index

  5. Journal of Medicinal Chemistry

    1 publications · 76 citations

    1

    h-index

1–5